MADISON, Wis.--(BUSINESS WIRE)--Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from ...
Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...
An advanced computerized decision support technology to support breast multidisciplinary meetings. The influence of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in ...
Due to their diverse functions, antibodies (Abs) can fight viral infections on multiple fronts. For example, neutralizing antibodies (nAbs) can block viral entry into cells, whereas non-neutralizing ...
Developing an effective vaccine against HIV requires eliciting the production of antibodies that will not only recognize and bind proteins present on the virus particle’s surface, but also block viral ...
Complex biology cannot be modeled with simple, standalone in vitro systems. More sophisticated, physiologically relevant systems are needed. For example, systems that maintain cellular environments ...
NK cell-related immunotherapeutics, such as tumor-specific monoclonal antibodies (mAbs) to elicit NK cell-mediated ADCC against tumor cells, are being developed for the treatment of cancers. As an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results